allylamine has been researched along with Body Weight in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YL; Chuang, LM; Hung, CS; Kao, HL; Li, HY; Lin, MS; Su, CY; Tsai, FC; Wang, SH; Yang, CY; Yu, TY | 1 |
Holst, JJ; Salen, G; Saumoy, M; Shang, Q; Xu, G | 1 |
Holst, JJ; Liu, MK; Salen, G; Saumoy, M; Shang, Q; Xu, G | 1 |
Baker, BA; Dagher, R; Jones, MR; Marquis, JK | 1 |
Boor, PJ; Nelson, TJ | 1 |
Boor, PJ; Kumar, D; Trent, MB | 1 |
Coppen, A; Ramo Rao, VA; Swade, C; Wood, K | 1 |
Boor, PJ; Moslen, MT; Reynolds, ES | 1 |
Ramos, K | 1 |
Boor, PJ; Hysmith, RM; Kumar, D | 1 |
Apstein, CS; Aslanis, JT; Bing, OH; Nakamura, Y; Wiegner, AW | 1 |
1 trial(s) available for allylamine and Body Weight
Article | Year |
---|---|
Zimelidine: a therapeutic and pharmacokinetic study in depression.
Topics: Allylamine; Amitriptyline; Antidepressive Agents; Body Weight; Bridged Bicyclo Compounds; Depression; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Kinetics; Male; Middle Aged; Psychiatric Status Rating Scales; Pyridines | 1979 |
10 other study(ies) available for allylamine and Body Weight
Article | Year |
---|---|
Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
Topics: Allylamine; Amine Oxidase (Copper-Containing); Animals; Aorta; Apolipoproteins E; Atherosclerosis; Benzamides; Body Weight; Cell Adhesion Molecules; Cholesterol; Cytokines; Enzyme Inhibitors; Fasting; Feeding Behavior; Humans; Hydrogen Peroxide; Inflammation Mediators; Macrophage Activation; Male; Matrix Metalloproteinase 9; Mice; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Proliferating Cell Nuclear Antigen; Rabbits | 2018 |
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.
Topics: Allylamine; Animals; Anticholesteremic Agents; Bile Acids and Salts; Blood Glucose; Body Weight; Carrier Proteins; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Colesevelam Hydrochloride; Cyclic N-Oxides; Dietary Carbohydrates; Dietary Fats; Gene Expression; Glucagon-Like Peptide 1; Glucose Tolerance Test; Ileum; Insulin; Insulin Resistance; Liver; Male; Membrane Glycoproteins; Obesity; Organic Anion Transporters, Sodium-Dependent; Portal Vein; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Symporters; Triglycerides; Tropanes | 2010 |
The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
Topics: Allylamine; Animals; Anticholesteremic Agents; Apoptosis; Bile Acids and Salts; Blood Glucose; Body Weight; Cell Proliferation; Cell Size; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Diet; Drug Synergism; Fluorescent Antibody Technique; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; In Situ Nick-End Labeling; Insulin; Insulin-Secreting Cells; Ki-67 Antigen; Male; Postprandial Period; Pyrazines; Rats; Rats, Zucker; Receptors, G-Protein-Coupled; RNA, Messenger; Sitagliptin Phosphate; Triazoles | 2012 |
Colesevelam hydrochloride does not cause maternal or fetal toxicity in rats and rabbits.
Topics: Allylamine; Animals; Animals, Newborn; Anticholesteremic Agents; Birth Weight; Body Weight; Colesevelam Hydrochloride; Eating; Female; Fetus; Growth; Male; Maternal Behavior; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Reproduction | 2006 |
Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase.
Topics: Allylamine; Amines; Animals; Body Weight; Brain; Drinking; Heart; Hydralazine; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Rats; Semicarbazides | 1980 |
Allylamine and beta-aminopropionitrile induced aortic medial necrosis: mechanisms of synergism.
Topics: Allylamine; Aminopropionitrile; Analysis of Variance; Animals; Aorta; Body Weight; Diet; Drug Synergism; Male; Muscle, Smooth, Vascular; Necrosis; Rats; Rats, Sprague-Dawley; Survival Rate | 1998 |
Allylamine cardiotoxicity: I. Sequence of pathologic events.
Topics: Allylamine; Amines; Animals; Body Weight; Cardiomyopathies; Creatine Kinase; Male; Myocardium; Organ Size; Rats; Time Factors | 1979 |
Comparative angiotoxic responses of avian and rodent species in vivo: implications in atherogenesis.
Topics: Administration, Oral; Allylamine; Amines; Animals; Aorta, Thoracic; Arteriosclerosis; Body Weight; Cholesterol; Coturnix; Disease Susceptibility; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred Strains; Species Specificity | 1990 |
Allylamine and beta-aminopropionitrile-induced vascular injury: an in vivo and in vitro study.
Topics: Allylamine; Amines; Aminopropionitrile; Animals; Aorta; Body Weight; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Male; Muscle, Smooth, Vascular; Myocardium; Rats; Rats, Inbred Strains; Swine; Time Factors | 1990 |
Myocardial mechanics in allylamine-induced myocardial fibrosis.
Topics: Allylamine; Animals; Biomechanical Phenomena; Body Weight; Endomyocardial Fibrosis; Heart; Hydroxyproline; In Vitro Techniques; Male; Myocardium; Organ Size; Papillary Muscles; Rats; Rats, Inbred Strains | 1986 |